1. Home
  2. APLS vs APPN Comparison

APLS vs APPN Comparison

Compare APLS & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$23.62

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$40.96

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLS
APPN
Founded
2009
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
APLS
APPN
Price
$23.62
$40.96
Analyst Decision
Buy
Hold
Analyst Count
19
6
Target Price
$33.11
$38.40
AVG Volume (30 Days)
2.4M
841.0K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
$1,016,397,000.00
$690,755,000.00
Revenue This Year
$29.00
$17.93
Revenue Next Year
N/A
$11.99
P/E Ratio
$65.98
N/A
Revenue Growth
42.11
15.96
52 Week Low
$16.10
$24.00
52 Week High
$35.72
$46.06

Technical Indicators

Market Signals
Indicator
APLS
APPN
Relative Strength Index (RSI) 62.06 57.48
Support Level $20.51 $38.51
Resistance Level $21.72 $41.58
Average True Range (ATR) 0.81 1.65
MACD 0.51 -0.57
Stochastic Oscillator 92.66 46.69

Price Performance

Historical Comparison
APLS
APPN

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: